Traffic Lights - Latest Updates

Last updated: 05/09/2022

Other updates on this site
Drug Name Classification Clinical Indication Comments
ACETYLCYSTEINE NEBULISED Red Last line mucolytic treatment to loosen tenacious secretions. Under supervision of a senior respiratory physiotherapist only.
Azathioprine 75mg & 100mg Do not prescribe Autoimmune Conditions

Increased risk of medication errors with 75mg and 100mg tablets. Use 25mg and 50mg tablets only.

BUDESONIDE/ FORMOTEROL FUMARATE DIHYDRATE INHALER (GoResp Digihaler®) (UPDATED) Red Asthma & COPD

Restricted to severe asthma clinic only on a named patient basis

DORNASE ALFA (UPDATED) Red Cystic fibrosis

Red; all new patients. Yellow status for existing patients where patients are already in primary care

DORNASE ALFA Red Pleural Infections
HYPERTONIC SODIUM CHLORIDE, NEBULISED Yellow To loosen tenacious secretions. Under supervision of a respiratory physiotherapist.

Available as 3% and 7% solutions.

IBUPROFEN MR (NEW) Red Stat doses prior to day case surgery
NEFOPAM (UPDATED) Yellow Pain

Initiation restricted on advice of secondary care pain team only. Historic patients may continue therapy as appropriate.

PROBENECID Red Prevention of nephrotoxicity associated with cidofovir treatment
PROGESTERONE (Gepretix®) (UPDATED) Green For adjunctive use with an oestrogen in post-menopausal women with an intact uterus, as hormone replacement therapy (HRT).
SACUBITRIL and VALSARTAN (Entresto®) Yellow Heart failure

For background and information and monitoring requirements, (in line with ACEI/ARB monitoring for heart failure), please see interim information whilst the heart failure guide is being updated.

 

SACUBITRIL AND VALSARTAN (Entresto®) (NEW) Red Paediatric heart failure
TROPOLONE (NEW) Red Platelet labelling in nuclear medicine

Other Updates on this Website

Recent documents from LLR APC and TAS


About the Leicester, Leicestershire and Rutland Area Prescribing Committee

In common with other local health communities, the Leicester, Leicestershire and Rutland Area Prescribing Committee (LLR APC) acknowledges the benefits of having a Leicestershire Health Community-wide strategy for the prescribing of specialist medicines and the managed entry of new drugs and related technologies.

Leicestershire Health Community comprises the Leicester, Leicestershire and Rutland Integrated Care Board, University Hospitals of Leicester (UHL) NHS Trust and Leicestershire Partnership NHS Trust (LPT), amongst which there is a total consensus on the need for this strategy, and the LLR APC has been in place since 2005. Learn more